Philip Wagenheim

CIK: 0001405684

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (22.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)3 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

SWMR

Swarmer, Inc

Director

IMNM

Immunome Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

SWMR
Swarmer, Inc
Oct 1, 2026
Award(A)
Stock Option (right to buy)
Direct
6.4K shares-
SWMR
Swarmer, Inc
Sep 16, 2026
In-the-Money(X)
Indirect
819.5K shares at avg. $3.33$2.7M
SWMR
Swarmer, Inc
Sep 15, 2026
Other(J)
Indirect
1.1M shares-
SWMR
Swarmer, Inc
Aug 13, 2026
Award(A)
Stock Option (right to buy)
Direct
2.5K shares-
IMNM
Immunome Inc.
Jun 10, 2026
Award(A)
Director Stock Option (right to buy)
Direct
9.9K shares-
IMNM
Immunome Inc.
Mar 23, 2026
Sale(S)
Direct
28.2K shares at avg. $20.65$582K
IMNM
Immunome Inc.
Mar 20, 2026
Sale(S)
Direct
36.8K shares at avg. $20.47$753K
SWMR
Swarmer, Inc
Mar 18, 2026
Conversion(C)
Indirect
1.1M shares-
IMNM
Immunome Inc.
Jun 10, 2025
Award(A)
Director Stock Option (right to buy)
Direct
18.9K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	SWMR Swarmer, Inc	Award(A) Stock Option (right to buy)	6,428	-	-	Direct
Sep 16, 2026	SWMR Swarmer, Inc	In-the-Money(X)	819,487	$3.33	$2,731,678	Indirect
Sep 15, 2026	SWMR Swarmer, Inc	Other(J)	1,124,981	-	$0	Indirect
Aug 13, 2026	SWMR Swarmer, Inc	Award(A) Stock Option (right to buy)	2,511	-	-	Direct
Jun 10, 2026	IMNM Immunome Inc.	Award(A) Director Stock Option (right to buy)	9,897	-	-	Direct
Mar 23, 2026	IMNM Immunome Inc.	Sale(S)	28,200	$20.65	$582,330	Direct
Mar 20, 2026	IMNM Immunome Inc.	Sale(S)	36,800	$20.47	$753,296	Direct
Mar 18, 2026	SWMR Swarmer, Inc	Conversion(C)	1,124,981	-	$0	Indirect
Jun 10, 2025	IMNM Immunome Inc.	Award(A) Director Stock Option (right to buy)	18,864	-	-	Direct

1-9 of 9 transactions

About WAGENHEIM PHILIP

WAGENHEIM PHILIP (SEC CIK 0001405684) files insider reports with the SEC as Director of Swarmer, Inc (SWMR) and Director of Immunome Inc. (IMNM).

Signal8 holds 8 ownership filings by WAGENHEIM PHILIP (1 Form 3, 7 Form 4), filed between Jun 12, 2025 and Oct 2, 2026. Those filings report 9 transactions, from Jun 10, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WAGENHEIM PHILIP's filings is in AUSTIN, TX.

Recent filings by WAGENHEIM PHILIP

Oct 1, 2026: Grant or award of SWMR derivative securities (Form 4, code A).
Sep 16, 2026: Option exercise of SWMR shares (Form 4, code X).
Sep 15, 2026: Other transaction of SWMR shares (Form 4, code J).
Aug 13, 2026: Grant or award of SWMR derivative securities (Form 4, code A).
Jun 10, 2026: Grant or award of IMNM derivative securities (Form 4, code A).

Other insiders filing for Swarmer, Inc (SWMR)

How to read Form 4 transaction codes